News

Boston Scientific Corporation announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation...

More physicians will soon be evaluating an innovative radio frequency (RF) needle developed by Baylis Medical Company Inc. as part of a cross-Canada clinical trial in people with atrial fibrillation (AF). It is the most common heart...

Marks first Chinese approval for the pacemakers manufactured by the companies’ joint venture LivaNova PLC and MicroPort Scientific Corporation announced that the companies’ Shanghai-based joint venture MicroPort Sorin Cardiac Rhythm...

Patients with End-Stage Heart Failure Now Have New Options for Care Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients with advanced heart...

 CardioFocus, Inc. announced the European CE Mark approval of the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of atrial fibrillation (AF). The Excalibur Balloon leverages the proven universal...

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, announced that it has launched the AtriClip PRO•V™ Left Atrial Appendage (LAA) Exclusion System in the United States. The...

G3 Pharmaceuticals, a newly formed biopharmaceutical company, announced the start of its research and development program to pursue novel galectin-3 inhibitors. Galectin-3 is a protein that is responsible for fibrosis forming in the heart and...

Ncardia has been established following the merger of Pluriomics and Axiogenesis. The privately held company with operations in Europe and the US, produces and commercializes high-quality, fully functional hiPSC derived cardiovascular and...

BERLIN, Germany & SOPHIA ANTIPOLIS, France, August 29, 2017 – The European Heart Rhythm Association (EHRA) released the analytical supplement to the 10th EHRA White Book during the ESC Congress 2017 in Barcelona. Supported by BIOTRONIK,...

On August 4, 2017, Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, was honored with the 2017 Eric N....